AdCAIL-2 (McMaster University)

N/A

Report date: 2023/10/26 16:03:52

Base Information

Drug NameAdCAIL-2 (McMaster University)
Drug Alias Nameinterleukin-2 gene therapy
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionInterleukin-2 stimulants
TargetsInterleukin-2
Therapy Area/IndicationsBreast NeoplasmsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMcmaster University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMcmaster University
Active IndicationsN/A
Inactive IndicationsBreast NeoplasmsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A